Latham & Watkins LLP and Cirio represented 10x Genomics, Inc. in the transaction. 10x Genomics, Inc. (Nasdaq: TXG) executed the Stockholm-based CartaNA AB, developers of In Situ…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
